ZYME Stock Analysis: Buy, Sell, or Hold?
ZYME - Zymeworks Inc.
$26.31
0.59 (2.29%)
▲
5d:
+10.69%
30d:
+9.12%
90d:
+1.43%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When ZYME Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ZYME shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ZYME shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.44
Based on -36.5% avg growth
INTRINSIC VALUE TODAY
$0.27
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ZYME is currently trading at $26.31, which is considered slightly low relative to its 30-day fair value range of $23.10 to $24.91. From a valuation perspective, the stock is trading at a premium (Forward PE: 81.8) compared to its historical average (59.6). At these levels, the market is pricing in 11.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ZYME is showing sideways momentum. Immediate support is located at $21.91, while resistance sits at $27.14.
Market Sentiment: ZYME has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $39.08 (+48.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ZYME is showing sideways momentum. Immediate support is located at $21.91, while resistance sits at $27.14.
Market Sentiment: ZYME has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $39.08 (+48.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$23.10 -
$24.91
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 48.5% below Wall St target ($39.08)
- NEUTRAL: Trading at premium valuation - market expects 11.1% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$23.10 -
$24.91
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$21.91
Resistance Level
$27.14
Current Trend
Sideways
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
81.78
Wall Street Target
$39.08
(+48.5%)
Revenue Growth (YoY)
-91.1%
Profit Margin
-126.3%
Valuation Premium vs History
+11.1% premium
PE vs Historical
81.8 vs 59.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+11.1%
(market-implied from PE analysis)
1-Year Target
$29.23
(+11%)
2-Year Target
$32.47
(+23%)
3-Year Target
$36.08
(+37%)
3-Yr Target (if PE normalizes)
(PE: 82→60)
PE COMPRESSION
$26.29
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 81.8, Growth: -77.0%)
$19.18
(+-27%)
Base:
(SPY PE: 21.8, Growth: -77.0%)
$5.11
(-81%)
Bear:
(PE: 18.5, Growth: -77.0%)
$4.34
(-84%)
Share & Embed Analysis
Last updated: July 03, 2026 5:04 PM ET
Data refreshes hourly during market hours. Next update: 6:04 PM
Data refreshes hourly during market hours. Next update: 6:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZYME showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeffrey T L Smith
SELL
9310 shares
2026-01-12
Kenneth Galbraith
SELL
30424 shares
2026-01-12
Mark Hollywood
SELL
6120 shares
2026-01-12
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 64 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
Advanced ZYME Option Strategies
Professional options setups generated by AI based on today's ZYME price and gamma walls.
